Orthopedic Imaging Equipment Market Outlook (2021 to 2031)
[174 Pages Report] The global Orthopedic Imaging Equipment Market was valued at US$ 9.8 Billion in 2021 and is expected to reach US$ 14.6 Billion by 2031. The increasing number of accidents and sports injuries resulting in fractures and bone injuries is boosting the need for orthopedic diagnostic imaging.
Data Points
Market Insights
Orthopedic Imaging Equipment Market Value 2020
US$ 9.3 Billion
Orthopedic Imaging Equipment Market Market Value 2031
US$ 14.6 Billion
CAGR 2021 to 2031
4.0%
Share of Top 5 Countries
58.6%
Key Players
General Electric Healthcare Limited, Siemens AG, Esaote SPA, Hitachi Ltd, Koninklijke Philips N.V, PLANMED OY, EOS imaging
Imaging technologies such as magnetic resonance imaging (MRI), computed tomography (CT or CAT), and ultrasound have opened new therapy possibilities with little morbidity. The increasing prevalence of orthopedic diseases such as osteoporosis, arthritis, elbow pain, and others have increased the demand for diagnosis and diagnostic equipment across the globe.
According to the Centers for Disease Control and Prevention (CDC), in The USA, around 72 million people will be affected by arthritis by 2030. Against this backdrop, demand for orthopedic imaging equipment is expected to bolster in the USA, making it one of the most lucrative pockets in the global market.
The orthopedic imaging equipment market holds nearly 31% of the medical imaging equipment market, totaling US$ 29.5 Billion by the end of 2031. There have been significant developments in medical imaging technology and orthopedic imaging equipment devices.
Subsequently, increased rates of bone disease and accidents resulting in bone injuries are driving the need for effective orthopedic diagnostic imaging.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
4.84%
H1, 2022 Projected
3.94%
H1, 2022 Outlook
3.64%
BPS Change - H1, 2022 (O) - H1, 2022 (P)
(-) 30 ↓
BPS Change - H1, 2022 (O) - H1, 2021
(-) 120 ↓
The global orthopaedic imaging equipment market is subject to devise regulations, product patents, licensing requirements, and quality and safety assessment, as per all the macro and industry standards.
The key developments in the market include the development of advanced 3D imaging and software modelling of the target imaging field. The market is highly influenced by the growing adoption of portable or hand-held imaging devices, and the utilization of predictive modelling to identify surgical interventional sites for enhanced patient compliance with treatment.
The H1-2022 outlook period in comparison to H1-2022 projected period showed negative growth in terms of Basis Point Share by 30 BPS. And in H1-2022, the market growth rate of orthopaedic imaging equipment is expected to fall by 120 basis point shares (BPS), as per FMI analysis
The market decline observed through the reduction in the BPS values is addressed by the risk of radiation exposure during imaging, lack of qualified professional workforce to operate advanced imaging modalities, and high initial equipment cost followed by subsequently high maintenance costs.
Orthopedic Imaging Equipment Market Analysis 2016 to 2020 Vs Demand Outlook for 2021 to 2031
According to Future Market Insights, sales of orthopedic imaging equipment grew at a CAGR of 4.0% between 2016 and 2020. With the rising incidence of orthopedic diseases and bone injuries coupled with a growing geriatric population, sales are expected to reach US$ 14.6 Billion by the end of 2031.
According to a UN report, the geriatric population will increase from 9.3 % in 2020 to around 16% in 2050. This increase in population will result in more acute and chronic injuries. Hence, demand for orthopedic imaging equipment is expected to increase, boosting the market.
Additionally, the global prevalence of osteoarthritis (OA) is rapidly increasing. Also, there has been a noticeable increase in the obesity ratio across the globe. Being overweight increases the pressure exerted on joints such as the knee, causing tension and speeding up cartilage breakdown.
Hence, the risk of bone and chronic injuries is expected to accelerate over the coming years. This is expected to create growth opportunities for the orthopedic imaging equipment market players.
Consequently, there is also a significant shift in doctors’ preference towards innovative and advanced technologies such as advanced MRI and CT imaging techniques. Development in these techniques will result in increased demand in the market.
Further, the orthopedic imaging equipment market is expected to grow with the expansion of the healthcare industry and the surging need to discover novel technologies to effectively diagnose any issue.
Rising acceptance and quick expansion of new technologies, especially in emerging economies such as India and China will boost the market throughout the forecast period. Hence, leading companies are concentrating on introducing new products as well as research and development.
Considering this, FMI expects the global orthopedic imaging equipment market to expand at over a CAGR of 5.4%, in terms of volume, through 2021.
High Cost and Lack of Healthcare Infrastructure to Limit Sales in Underdeveloped Economies
Currently, several developing and underdeveloped nations are lacking adequate imaging infrastructure to conduct tests and technology implementation. Developed nations such as the USA have better diagnostic imaging and use advanced imaging techniques.
However, with few reimbursement policies and a lack of healthcare infrastructure, the market in underdeveloped economies in Latin America is expected to witness headwinds in the upcoming years.
These economies lack widespread access to diagnostic imaging, limiting the sales in the orthopedic imaging equipment market.
Besides this, the high cost involved in the initial setup and installation of imaging equipment and broadband technology in remote locations might hamper the growth of the global orthopedic imaging equipment market.
Additionally, the chances of recovering the costs solely depend on the number of scans arriving per day. Hence, achieving break-even is quite uncertain and entails high risk. This is expected to be the major restraining factor in the orthopedic imaging equipment market.
Find your sweet spots for generating winning opportunities in this market.
Country-wise Insights
Why is the USA Considered the Largest Market for Orthopedic Imaging Equipment?
In 2021, the USA is expected to account for about 89.2% of the North American orthopedic imaging equipment market. Growing incidence of arthritis, acute injuries, increasing geriatric population, and high per capita healthcare spending in the USA are some of the factors boosting the market.
Furthermore, government funding for the procurement of imaging equipment by various institutions in the USA will aid the expansion of the market.
Will the UK Emerge as the Most Lucrative Pocket in Europe Orthopedic Imaging Equipment?
As per FMI, the UK is expected to account for 13.1%of the Europe market by 2021. Growth in the country is attributable to the technological advancements in medical devices used in orthopedic imaging and favorable government policies.
As per the National Health Service (UK), more than ten million individuals suffer from arthritis or other joint-related diseases. The rising prevalence of such bone diseases will improve the demand for orthopedic imaging equipment and treatment, accelerating sales in the UK.
What are the Factors Fueling the Demand in China's Orthopedic Imaging Equipment Market?
China is projected to witness growth at a 6.9% CAGR in East Asia throughout the forecast period, opines Future Market Insights.
The increasing geriatric population and growing prevalence of osteoarthritis and other bone diseases are propelling the growth of China's orthopedic imaging equipment market.
According to the World Health Organization (WHO), by 2040, the geriatric population is expected to grow by 28% in China.
How will the Orthopedic Imaging Equipment Market Expand Across India?
Demand for orthopedic imaging equipment in India is expected to rise at an impressive 6.3% CAGRover the forecast period, finds Future Market Insights.
Increasing research and development activities, rapid growth in medical device technology, and increasing adoption of medical devices are aiding the growth of the orthopedic imaging equipment market in India.
Category-wise Insights
Why are X-Ray Systems Most Preferred as Orthopedic Imaging Equipment?
By product, the X-ray system segment is anticipated to hold the maximum share of 28.0 % in 2021. The segment is expected to exhibit growth at 3.3% CAGR during the forecast period.
The demand for X-rays is expected to outpace the sales of other imaging equipment, owing to several advantages of X-rays such as easy availability, accessibility, and cost-effectiveness.
They are more accessible than MRI and can be used to identify injuries and masses within the body more quickly. X-rays are one of the most cost-effective and widely used imaging techniques across developing economies such as India and China.
Will the Increase Prevalence of Acute Injuries Propel Orthopedic Imaging Equipment Sales?
In terms of indication, the acute injuries segment is projected to dominate the market. As per FMI, the segment is expected to account for 56.6% of the total market share in 2021.
Growth in the segment is underpinned by an increase in accidental cases, sports injuries, and bone dislocation across the globe. According to the research study on acute injuries, over 30 million children participate in organized sports activities, among them nearly 3.5 million undergo severe acute injuries.
More than 775,000 children are treated in hospital emergency rooms for such injuries, resulting in the need for advanced orthopedic imaging equipment.
Will Need for Orthopedic Imaging Equipment in Hospitals Outpace in Radiology Centers?
In terms of end-user, hospitals, and radiology centers, collectively, hold over 60% of the market share in 2021 and this trend is expected to continue during the forecast period as well.
A growing number of standalone imaging centers is propelling the growth in the radiology centers segment. Also, independent imaging centers provide discounts in order to attract more people, aiding the growth of the segment.
In addition, the time it takes for patients to have an MRI or other imaging procedure in radiology centers is reduced. Hence, the adoption of orthopedic imaging equipment will increase in radiology centers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Competitive Landscape
Companies in the orthopedic imaging equipment market are pursuing new product innovations and launches, regulatory approvals, and expansion of their product portfolios as key strategies.
Key players are also focusing on the development of advanced and cost-effective products establishing distribution agreements to expand their global footprints, especially in Asia Pacific.
Moreover, companies are targeting Indian and China markets by establishing manufacturing units in order to reduce manufacturing costs. For instance:
Canon Inc. purchased Toshiba Corp.'s medical division in December 2016. Canon Inc. has joined the diagnostic imaging devices market as a result of the purchase, using Toshiba Medicals' diagnostic imaging expertise. Canon's biomedical industry would be strengthened much more as a result of this purchase.
On September 2016, FDA approved the OnSight 3D Extremity System by Carestream Health. This system offers high-quality point-of-care imaging for sports and orthopedic practices.
Siemens Healthineers opened its next-generation manufacturing plant in Bengaluru in September 2019, with a total investment of INR 200 million, to create diagnostic imaging and advanced therapies products.
Scope of the Report
Attribute
Details
Forecast Period
2021 to 2031
Historical Data Available for
2016 to 2020
Market Analysis
USD Million for Value
Key Regions Covered
North America, Latin America, Europe, South Asia and Pacific, East Asia, and Middle East & Africa (MEA)
Key Countries Covered
The USA, Canada, Brazil, Mexico, Argentina, Germany, The UK, France, Italy, Spain, Benelux, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Thailand, Indonesia, Australia, and New Zealand, Egypt, Turkey, South Africa, North Africa, and GCC Countries
The global orthopedic imaging equipment market is worth US$ 9.8 Billion in 2021 and is set to expand by 1.5X over the next ten years.
The orthopedic imaging equipment market is expected to reach US$ 14.6 Billion, with sales increasing at a 4.0% CAGR by the end of 2031.
Sales in the orthopedic imaging equipment market are expected to increase owing to the rising government and private body initiatives and surging demand for 3D medical imaging equipment.
North America currently holds the largest market share in the orthopedic imaging equipment market globally. The region is expected to contribute over 30.5% of the sales in the orthopedic imaging equipment market. As per FMI, the USA is expected to spearhead the growth, surpassing US$ 2.5 Billion in 2021.
Japan’s market for orthopedic imaging equipment is expected to exhibit healthy growth at 4.3% CAGR during the forecast period.
The USA, Russia, Poland, China, and Japan are the top 5 countries driving the demand in the orthopedic imaging equipment market.
Table of Content
1. Executive Summary | Orthopaedic Imaging Equipment Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Technological Roadmap
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Key Development Trends
3.3. New Launches / Approvals
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Expenditure Outlook
4.1.3. Emerging Countries Healthcare and Development Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Adoption of Device Product
4.2.2. Prevalence of Orthopaedic Disorders
4.2.3. Historical growth of key players
4.2.4. New product launches and approvals
4.2.5. COVID-19 Impact
4.2.6. Reimbursement scenario
4.2.7. Expansion by Leading Manufacturer in Emerging Geographies
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. Market Context
5.1. List of Manufacturers and Suppliers
5.2. Usage/ Adoption Analysis
5.3. Promotional Strategies by Key Manufacturer
5.4. Technological Advancements
5.5. Regulatory Scenario
5.6. Porter’s Analysis
5.7. PESTLE Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as Compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Product
6.4.2. Revenue By Indication
6.4.3. Revenue By End User
6.4.4. Revenue By Region
6.5. 2021 Market Scenario
7. Global Market Volume (Units) Analysis 2016 to 2020 and Forecast, 2021 to 2031
7.1. Historical Market Volume (Units) Analysis, 2016 to 2020
7.2. Current and Future Market Volume (Units) Projections, 2021 to 2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Market -Pricing Analysis
8.1. Regional Pricing Analysis By Indication
8.2. Pricing Break-up
8.2.1. Manufacturer-Level Pricing
8.2.2. Distributor Level Pricing
8.3. Average Pricing Analysis Benchmark
9. Global Market Value (US$ Million) Analysis 2016 to 2020 and Forecast, 2021 to 2031
9.1. Historical Market Value (US$ Million) Analysis, 2016 to 2020
9.2. Current and Future Market Value (US$ Million) Projections, 2021 to 2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Product, 2016 to 2020
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2021 to 2031
10.3.1. X-Ray Systems
10.3.2. CT-Scanner
10.3.3. Orthopaedic Imaging Equipment
10.3.4. EOS Imaging Systems
10.3.5. Ultrasound
10.3.6. Nuclear Imaging Systems
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis, By Indication, 2016 to 2020
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2021 to 2031
11.3.1. Acute injuries
11.3.1.1. Sports injuries
11.3.1.2. Trauma cases
11.3.2. Chronic Disorders
11.3.2.1. Osteoarthritis
11.3.2.2. Osteoporosis
11.3.2.3. Prolapsed Disc
11.3.2.4. Degenerative joint diseases
11.3.3. Market Attractiveness Analysis By Indication
12. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By End User, 2016 to 2020
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2021 to 2031
12.3.1. Hospitals
12.3.2. Radiology Centers
12.3.3. Emergency Care Facility
12.3.4. Ambulatory Surgical Centres
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2016 to 2020
13.3. Current Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2021 to 2031
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
14.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
14.3.1. By Country
14.3.1.1. The USA
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
15.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
16.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
16.3.1. By Country
16.3.1.1. The UK
16.3.1.2. Germany
16.3.1.3. France
16.3.1.4. Italy
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. BENELUX
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Indication
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
17.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Indication
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
18.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.1.4. Rest of East Asia
18.3.2. By Product
18.3.3. By Indication
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2016 to 2020 and Forecast 2021 to 2031
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
19.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Indication
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2016 to 2020 and Forecast 2021 to 2031
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
20.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. Northern Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Indication
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Countries Level Market Analysis 2021 & 2031
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.1.3. Pricing Analysis
21.2. The USA Market Analysis
21.2.1. By Product
21.2.2. By Indication
21.2.3. By End User
21.3. Canada Market Analysis
21.3.1. By Product
21.3.2. By Indication
21.3.3. By End User
21.4. Mexico Market Analysis
21.4.1. By Product
21.4.2. By Indication
21.4.3. By End User
21.5. Brazil Market Analysis
21.5.1. By Product
21.5.2. By Indication
21.5.3. By End User
21.6. The UK Market Analysis
21.6.1. By Product
21.6.2. By Indication
21.6.3. By End User
21.7. Germany Market Analysis
21.7.1. By Product
21.7.2. By Indication
21.7.3. By End User
21.8. France Market Analysis
21.8.1. By Product
21.8.2. By Indication
21.8.3. By End User
21.9. Italy Market Analysis
21.9.1. By Product
21.9.2. By Indication
21.9.3. By End User
21.10. Spain Market Analysis
21.10.1. By Product
21.10.2. By Indication
21.10.3. By End User
21.11. BENELUX Market Analysis
21.11.1. By Product
21.11.2. By Indication
21.11.3. By End User
21.12. Russia Market Analysis
21.12.1. By Product
21.12.2. By Indication
21.12.3. By End User
21.13. China Market Analysis
21.13.1. By Product
21.13.2. By Indication
21.13.3. By End User
21.14. Japan Market Analysis
21.14.1. By Product
21.14.2. By Indication
21.14.3. By End User
21.15. South Korea Market Analysis
21.15.1. By Product
21.15.2. By Indication
21.15.3. By End User
21.16. India Market Analysis
21.16.1. By Product
21.16.2. By Indication
21.16.3. By End User
21.17. Indonesia Market Analysis
21.17.1. By Product
21.17.2. By Indication
21.17.3. By End User
21.18. Thailand Market Analysis
21.18.1. By Product
21.18.2. By Indication
21.18.3. By End User
21.19. Malaysia Market Analysis
21.19.1. By Product
21.19.2. By Indication
21.19.3. By End User
21.20. Australia Market Analysis
21.20.1. By Product
21.20.2. By Indication
21.20.3. By End User
21.21. New Zealand Market Analysis
21.21.1. By Product
21.21.2. By Indication
21.21.3. By End User
21.22. GCC Countries Market Analysis
21.22.1. By Product
21.22.2. By Indication
21.22.3. By End User
21.23. Turkey Market Analysis
21.23.1. By Product
21.23.2. By Indication
21.23.3. By End User
21.24. South Africa Market Analysis
21.24.1. By Product
21.24.2. By Indication
21.24.3. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Share Analysis of Top Players
22.3. Market Concentration
22.4. Market Presence Analysis
22.4.1. By Regional Footprint of Players
22.4.2. Product foot print by Players
22.4.3. Channel foot print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. GE Healthcare
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Analyst Commentary
23.3.1.4. Key Financials
23.3.1.5. Recent Developments
23.3.1.6. Profitability by Market Segments (Product / Channel / Region)
23.3.1.7. Sales Footprint
23.3.1.8. Strategy Overview
23.3.1.8.1. Marketing Strategy
23.3.1.8.2. Product Strategy
23.3.1.8.3. Channel Strategy
23.3.2. Koninklijke Philips N.V.
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Analyst Commentary
23.3.2.4. Key Financials
23.3.2.5. Recent Developments
23.3.2.6. Profitability by Market Segments (Product / Channel / Region)
23.3.2.7. Sales Footprint
23.3.2.8. Strategy Overview
23.3.2.8.1. Marketing Strategy
23.3.2.8.2. Product Strategy
23.3.2.8.3. Channel Strategy
23.3.3. Siemens Healthineers
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Analyst Commentary
23.3.3.4. Key Financials
23.3.3.5. Recent Developments
23.3.3.6. Profitability by Market Segments (Product / Channel / Region)
23.3.3.7. Sales Footprint
23.3.3.8. Strategy Overview
23.3.3.8.1. Marketing Strategy
23.3.3.8.2. Product Strategy
23.3.3.8.3. Channel Strategy
23.3.4. Esaote SPA
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Analyst Commentary
23.3.4.4. Key Financials
23.3.4.5. Recent Developments
23.3.4.6. Profitability by Market Segments (Product / Channel / Region)
23.3.4.7. Sales Footprint
23.3.4.8. Strategy Overview
23.3.4.8.1. Marketing Strategy
23.3.4.8.2. Product Strategy
23.3.4.8.3. Channel Strategy
23.3.5. Canon Medical Systems, Inc.,
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Analyst Commentary
23.3.5.4. Key Financials
23.3.5.5. Recent Developments
23.3.5.6. Profitability by Market Segments (Product / Channel / Region)
23.3.5.7. Sales Footprint
23.3.5.8. Strategy Overview
23.3.5.8.1. Marketing Strategy
23.3.5.8.2. Product Strategy
23.3.5.8.3. Channel Strategy
23.3.6. Hitachi Medical Systems
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Analyst Commentary
23.3.6.4. Key Financials
23.3.6.5. Recent Developments
23.3.6.6. Profitability by Market Segments (Product / Channel / Region)
23.3.6.7. Sales Footprint
23.3.6.8. Strategy Overview
23.3.6.8.1. Marketing Strategy
23.3.6.8.2. Product Strategy
23.3.6.8.3. Channel Strategy
23.3.7. PLANMED OY
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Analyst Commentary
23.3.7.4. Key Financials
23.3.7.5. Recent Developments
23.3.7.6. Profitability by Market Segments (Product / Channel / Region)
23.3.7.7. Sales Footprint
23.3.7.8. Strategy Overview
23.3.7.8.1. Marketing Strategy
23.3.7.8.2. Product Strategy
23.3.7.8.3. Channel Strategy
23.3.8. EOS imaging
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Analyst Commentary
23.3.8.4. Key Financials
23.3.8.5. Recent Developments
23.3.8.6. Profitability by Market Segments (Product / Channel / Region)
23.3.8.7. Sales Footprint
23.3.8.8. Strategy Overview
23.3.8.8.1. Marketing Strategy
23.3.8.8.2. Product Strategy
23.3.8.8.3. Channel Strategy
23.3.9. Neusoft Corporation
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Analyst Commentary
23.3.9.4. Key Financials
23.3.9.5. Recent Developments
23.3.9.6. Profitability by Market Segments (Product / Channel / Region)
23.3.9.7. Sales Footprint
23.3.9.8. Strategy Overview
23.3.9.8.1. Marketing Strategy
23.3.9.8.2. Product Strategy
23.3.9.8.3. Channel Strategy
23.3.10. Carestream Health
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Analyst Commentary
23.3.10.4. Key Financials
23.3.10.5. Recent Developments
23.3.10.6. Profitability by Market Segments (Product / Channel / Region)
23.3.10.7. Sales Footprint
23.3.10.8. Strategy Overview
23.3.10.8.1. Marketing Strategy
23.3.10.8.2. Product Strategy
23.3.10.8.3. Channel Strategy
24. Assumptions and Acronyms Used25. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 02: Global Market Volume (Units) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 03: Global Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication
Table 04: Global Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By End User
Table 05: Global Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Region
Table 06: Global Market Volume (Units) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Region
Table 07: North America Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 08: North America Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 09: North America Market Volume (Units) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 10: North America Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication
Table 11: North America Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By End User
Table 12: Latin America Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 13: Latin America Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 14: Latin America Market Volume (Units) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 15: Latin America Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication
Table 16: Latin America Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By End User
Table 17: Europe Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 18: Europe Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 19: Europe Market Volume (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 20: Europe Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication
Table 21: Europe Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By End User
Table 22: South Asia Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 23: South Asia Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 24: South Asia Market Volume (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 25: South Asia Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication
Table 26: South Asia Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By End User
Table 27: East Asia Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 28: East Asia Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 29: East Asia Market Volume (Units) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 30: East Asia Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication
Table 31: East Asia Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By End User
Table 32: Oceania Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 33: Oceania Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 34: Oceania Market Volume (Units) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 35: Oceania Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication
Table 36: Oceania Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By End User
Table 37: MEA Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 38: MEA Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 39: MEA Market Volume (Units) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 40: MEA Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication
Table 41: MEA Market Value (US$ Million) Analysis 2016 to 2020 and Forecast 2021 to 2031, By End Use
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Market Revenue Share, By Product (2021E)
Figure 02: Global Market Revenue Share, By Indication (2021E)
Figure 03: Global Market Revenue Share, By End User (2021E)
Figure 04: Global Average Pricing Analysis Benchmark USD (2020)
Figure 05: Global Market: X-ray System, CT scanner, MRI system, EOS Imaging Systems, Ultrasound and Nuclear Imaging Systems Price Difference (US$) By Region, 2031
Figure 06: Global Historical Volume (Units) Analysis, 2016 to 2020
Figure 07: Global Market Volume (Units) & Y-o-Y Growth (%), 2021 to 2031
Figure 08: Global Historical Market (US$ Million) Analysis, 2016 to 2020
Figure 09: Global Market Value (US$) & Y-o-Y Growth (%), 2021 to 2031
Figure 10: Global Market Absolute $ Opportunity, 2020 to 2031
Figure 11: Global Market Share Analysis (%) By Product, 2021 to 2031
Figure 12: Global Market Y-o-Y Growth (%) By Product, 2021 to 2031
Figure 13: Global Market Attractiveness Analysis by Product
Figure 14: Global Market Share Analysis (%) By Indication, 2021 to 2031
Figure 15: Global Market Y-o-Y Growth (%) By Indication, 2021 to 2031
Figure 16: Global Market Attractiveness Analysis by Indication
Figure 17: Global Market Share Analysis (%) By End User, 2021 to 2031
Figure 18: Global Market Y-o-Y Growth (%) By End User, 2021 to 2031
Figure 19: Global Market Attractiveness Analysis by End User
Figure 20: Global Market Share Analysis (%) By Region, 2021 to 2031
Figure 21: Global Market Y-o-Y Growth (%) By Region, 2021 to 2031
Figure 22: Global Market Attractiveness Analysis by Region
Figure 23: North America Market Value Share, By Product (2021 E)
Figure 24: North America Market Value Share, By Indication (2021 E)
Figure 25: North America Market Value Share, By End User (2021 E)
Figure 26: North America Market Value Share, By Country (2021 E)
Figure 27: North America Market Value (US$ Million) Analysis, 2016 to 2020
Figure 28: North America Market Size (US$ Million) & Y-o-Y Growth (%), 2021 to 2031
Figure 29: North America Market Attractiveness Analysis, By Country
Figure 30: North America Market Attractiveness Analysis, By Product
Figure 31: North America Market Attractiveness Analysis, By Indication
Figure 32: North America Market Attractiveness Analysis, By End User
Figure 33: Latin America Market Value Share, By Product (2021 E)
Figure 34: Latin America Market Value Share, By Indication (2021 E)
Figure 35: Latin America Market Value Share, By End User (2021 E)
Figure 36: Latin America Market Value Share, By Country (2021 E)
Figure 37: Latin America Market Value (US$ Million) Analysis, 2016 to 2020
Figure 38: Latin America Market Size (US$ Million) & Y-o-Y Growth (%), 2021 to 2031
Figure 39: Latin America Market Attractiveness Analysis, By Country
Figure 40: Latin America Market Attractiveness Analysis, By Product
Figure 41: Latin America Market Attractiveness Analysis, By Indication
Figure 42: Latin America Market Attractiveness Analysis, By End User
Figure 43: Europe Market Value Share, By Product (2021 E)
Figure 44: Europe Market Value Share, By Indication (2021 E)
Figure 45: Europe Market Value Share, By End User (2021 E)
Figure 46: Europe Market Value Share, By Country (2021 E)
Figure 47: Europe Market Value (US$ Million) Analysis, 2016 to 2020
Figure 48: Europe Market Size (US$ Million) & Y-o-Y Growth (%), 2021 to 2031
Figure 49: Europe Market Attractiveness Analysis, By Country
Figure 50: Europe Market Attractiveness Analysis, By Product
Figure 51: Europe Market Attractiveness Analysis, By Indication
Figure 52: Europe Market Attractiveness Analysis, By End User
Figure 53: South Asia Market Value Share, By Product (2021 E)
Figure 54: South Asia Market Value Share, By Indication (2021 E)
Figure 55: South Asia Market Value Share, By End User (2021 E)
Figure 56: South Asia Market Value Share, By Country (2021 E)
Figure 57: South Asia Market Value (US$ Million) Analysis, 2016 to 2020
Figure 58: South Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2021 to 2031
Figure 59: South Asia Market Attractiveness Analysis, By Country
Figure 60: South Asia Market Attractiveness Analysis, By Product
Figure 61: South Asia Market Attractiveness Analysis, By Indication
Figure 62: South Asia Market Attractiveness Analysis, By End User
Figure 63: East Asia Market Value Share, By Product (2021 E)
Figure 64: East Asia Market Value Share, By Indication (2021 E)
Figure 65: East Asia Market Value Share, By End User (2021 E)
Figure 66: East Asia Market Value Share, By Country (2021 E)
Figure 67: East Asia Market Value (US$ Million) Analysis, 2016 to 2020
Figure 68: East Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2021 to 2031
Figure 69: East Asia Market Attractiveness Analysis, By Country
Figure 70: East Asia Market Attractiveness Analysis, By Product
Figure 71: East Asia Market Attractiveness Analysis, By Indication
Figure 72: East Asia Market Attractiveness Analysis, By End User
Figure 73: Oceania Market Value Share, By Product (2021 E)
Figure 74: Oceania Market Value Share, By Indication (2021 E)
Figure 75: Oceania Market Value Share, By End User (2021 E)
Figure 76: Oceania Market Value Share, By Country (2021 E)
Figure 77: Oceania Market Value (US$ Million) Analysis, 2016 to 2020
Figure 78: Oceania Market Size (US$ Million) & Y-o-Y Growth (%), 2021 to 2031
Figure 79: Oceania Market Attractiveness Analysis, By Country
Figure 80: Oceania Market Attractiveness Analysis, By Product
Figure 81: Oceania Market Attractiveness Analysis, By Indication
Figure 82: Oceania Market Attractiveness Analysis, By End User
Figure 83: MEA Market Value Share, By Product (2021 E)
Figure 84: MEA Market Value Share, By Indication (2021 E)
Figure 85: MEA Market Value Share, By End User (2021 E)
Figure 86: MEA Market Value Share, By Country (2021 E)
Figure 87: MEA Market Value (US$ Million) Analysis, 2016 to 2020
Figure 88: MEA Market Size (US$ Million) & Y-o-Y Growth (%), 2021 to 2031
Figure 89: MEA Market Attractiveness Analysis, By Country
Figure 90: MEA Market Attractiveness Analysis, By Product
Figure 91: MEA Market Attractiveness Analysis, By Indication
Figure 92: MEA Market Attractiveness Analysis, By End User
Figure 93: The USA Market Value Proportion Analysis
Figure 94: Global Vs The USA Growth Comparison
Figure 95: The USA Market Share Analysis (%) By Product, 2021 to 2031
Figure 96: The USA Market Share Analysis (%) By Indication, 2021 to 2031
Figure 97: The USA Market Share Analysis (%) By End User, 2021 to 2031
Figure 98: Canada Market Value Proportion Analysis
Figure 99: Global Vs Canada Growth Comparison
Figure 100: Canada Market Share Analysis (%) By Product, 2021 to 2031
Figure 101: Canada Market Share Analysis (%) By Indication, 2021 to 2031
Figure 102: Canada Market Share Analysis (%) By End User, 2021 to 2031
Figure 103: Mexico Market Value Proportion Analysis
Figure 104: Global Vs Mexico Growth Comparison
Figure 105: Mexico Market Share Analysis (%) By Product, 2021 to 2031
Figure 106: Mexico Market Share Analysis (%) By Indication, 2021 to 2031
Figure 107: Mexico Market Share Analysis (%) By End User, 2021 to 2031
Figure 108: Brazil Market Value Proportion Analysis
Figure 109: Global Vs Brazil Growth Comparison
Figure 110: Brazil Market Share Analysis (%) By Product, 2021 to 2031
Figure 111: Brazil Market Share Analysis (%) By Indication, 2021 to 2031
Figure 112: Brazil Market Share Analysis (%) By End User, 2021 to 2031
Figure 113: The UK Market Value Proportion Analysis
Figure 114: Global Vs The UK Growth Comparison
Figure 115: The UK Market Share Analysis (%) By Product, 2021 to 2031
Figure 116: The UK Market Share Analysis (%) By Indication, 2021 to 2031
Figure 117: The UK Market Share Analysis (%) By End User, 2021 to 2031
Figure 118: Germany Market Value Proportion Analysis
Figure 119: Global Vs Germany Growth Comparison
Figure 120: Germany Market Share Analysis (%) By Product, 2021 to 2031
Figure 121: Germany Market Share Analysis (%) By Indication, 2021 to 2031
Figure 122: Germany Market Share Analysis (%) By End User, 2021 to 2031
Figure 123: France Market Value Proportion Analysis
Figure 124: Global Vs France Growth Comparison
Figure 125: France Market Share Analysis (%) By Product, 2021 to 2031
Figure 126: France Market Share Analysis (%) By Indication, 2021 to 2031
Figure 127: France Market Share Analysis (%) By End User, 2021 to 2031
Figure 128: Italy Market Value Proportion Analysis
Figure 129: Global Vs Italy Growth Comparison
Figure 130: Italy Market Share Analysis (%) By Product, 2021 to 2031
Figure 131: Italy Market Share Analysis (%) By Indication, 2021 to 2031
Figure 132: Italy Market Share Analysis (%) By End User, 2021 to 2031
Figure 133: Spain Market Value Proportion Analysis
Figure 134: Global Vs Spain Growth Comparison
Figure 135: Spain Market Share Analysis (%) By Product, 2021 to 2031
Figure 136: Spain Market Share Analysis (%) By Indication, 2021 to 2031
Figure 137: Spain Market Share Analysis (%) By End User, 2021 to 2031
Figure 138: BENELUX Market Value Proportion Analysis
Figure 139: Global Vs BENELUX Growth Comparison
Figure 140: BENELUX Market Share Analysis (%) By Product, 2021 to 2031
Figure 141: BENELUX Market Share Analysis (%) By Indication, 2021 to 2031
Figure 142: BENELUX Market Share Analysis (%) By End User, 2021 to 2031
Figure 143: Russia Market Value Proportion Analysis
Figure 144: Global Vs Russia Growth Comparison
Figure 145: Russia Market Share Analysis (%) By Product, 2021 to 2031
Figure 146: Russia Market Share Analysis (%) By Indication, 2021 to 2031
Figure 147: Russia Market Share Analysis (%) By End User, 2021 to 2031
Figure 148: China Market Value Proportion Analysis
Figure 149: Global Vs China Growth Comparison
Figure 150: China Market Share Analysis (%) By Product, 2021 to 2031
Figure 151: China Market Share Analysis (%) By Indication, 2021 to 2031
Figure 152: China Market Share Analysis (%) By End User, 2021 to 2031
Figure 153: Japan Market Value Proportion Analysis
Figure 154: Global Vs Japan Growth Comparison
Figure 155: Japan Market Share Analysis (%) By Product, 2021 to 2031
Figure 156: Japan Market Share Analysis (%) By Indication, 2021 to 2031
Figure 157: Japan Market Share Analysis (%) By End User, 2021 to 2031
Figure 158: South Korea Market Value Proportion Analysis
Figure 159: Global Vs South Korea Growth Comparison
Figure 160: South Korea Market Share Analysis (%) By Product, 2021 to 2031
Figure 161: South Korea Market Share Analysis (%) By Indication, 2021 to 2031
Figure 162: South Korea Market Share Analysis (%) By End User, 2021 to 2031
Figure 163: India Market Value Proportion Analysis
Figure 164: Global Vs India Growth Comparison
Figure 165: India Market Share Analysis (%) By Product, 2021 to 2031
Figure 166: India Market Share Analysis (%) By Indication, 2021 to 2031
Figure 167: India Market Share Analysis (%) By End User, 2021 to 2031
Figure 168: Thailand Market Value Proportion Analysis
Figure 169: Global Vs Thailand Growth Comparison
Figure 170: Thailand Market Share Analysis (%) By Product, 2021 to 2031
Figure 171: Thailand Market Share Analysis (%) By Indication, 2021 to 2031
Figure 172: Thailand Market Share Analysis (%) By End User, 2021 to 2031
Figure 173: Indonesia Market Value Proportion Analysis
Figure 174: Global Vs Indonesia Growth Comparison
Figure 175: Indonesia Market Share Analysis (%) By Product, 2021 to 2031
Figure 176: Indonesia Market Share Analysis (%) By Indication, 2021 to 2031
Figure 177: Indonesia Market Share Analysis (%) By End User, 2021 to 2031
Figure 178: Malaysia Market Value Proportion Analysis
Figure 179: Global Vs Malaysia Growth Comparison
Figure 180: Malaysia Market Share Analysis (%) By Product, 2021 to 2031
Figure 181: Malaysia Market Share Analysis (%) By Indication, 2021 to 2031
Figure 182: Malaysia Market Share Analysis (%) By End User, 2021 to 2031
Figure 183: Australia Market Value Proportion Analysis
Figure 184: Global Vs Australian Growth Comparison
Figure 185: Australia Market Share Analysis (%) By Product, 2021 to 2031
Figure 186: Australia Market Share Analysis (%) By Indication, 2021 to 2031
Figure 187: Australia Market Share Analysis (%) By End User, 2021 to 2031
Figure 188: New Zealand Market Value Proportion Analysis
Figure 189: Global Vs New Zealand Growth Comparison
Figure 190: New Zealand Market Share Analysis (%) By Product, 2021 to 2031
Figure 191: New Zealand Market Share Analysis (%) By Indication, 2021 to 2031
Figure 192: New Zealand Market Share Analysis (%) By End User, 2021 to 2031
Figure 193: GCC Countries Market Value Proportion Analysis
Figure 194: Global Vs GCC Countries Growth Comparison
Figure 195: GCC Countries Market Share Analysis (%) By Product, 2021 to 2031
Figure 196: GCC Countries Market Share Analysis (%) By Indication, 2021 to 2031
Figure 197: GCC Countries Market Share Analysis (%) By End User, 2021 to 2031
Figure 198: Turkey Market Value Proportion Analysis
Figure 199: Global Vs Turkey Growth Comparison
Figure 200: Turkey Market Share Analysis (%) By Product, 2021 to 2031
Figure 201: Turkey Market Share Analysis (%) By Indication, 2021 to 2031
Figure 202: Turkey Market Share Analysis (%) By End User, 2021 to 2031
Figure 203: South Africa Market Value Proportion Analysis
Figure 204: Global Vs South Africa Growth Comparison
Figure 205: South Africa Market Share Analysis (%) By Product, 2021 to 2031
Figure 206: South Africa Market Share Analysis (%) By Indication, 2021 to 2031
Figure 207: South Africa Market Share Analysis (%) By End User, 2021 to 2031
